Osteoboost is the first and only non-pharmacological prescription treatment to demonstrate reduced loss of bone strength in postmenopausal womenRepresents the...
Secures Two Research Grants from Belgium's New Technological Innovation PartnershipLONDON, UK / ACCESSWIRE / January 18, 2024 / The Company...
Carolyn's strategic vision and experience will be integral to securing and creating top talent to advance Envision's priorities.FAIRFIELD, CT /...
Cannabix Technologies Inc. Fig. 1 Cannabix at North Louisiana Crime Lab Cannabix Technologies Inc. Fig. 2 Cannabix MSBS at North...
A post hoc analysis found the efficacy of camrelizumab plus rivoceranib was superior to sorafenib regardless of baseline liver function...
Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated Hepatitis SZN-043- Completed enrollment for the...
XOMA provided an $8 million non-dilutive royalty capital solution to Talphera XOMA will receive a 15% royalty on all commercial...
Highly Experienced Pharma Commercial and Business Development Executive in Addiction Treatment Space Joins Leadership Team While Continuing as Board MemberCharlottesville,...
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical...
Pioneering Soft-Tissue Simulation Company Reveals Latest TechnologySEATTLE, WA / ACCESSWIRE / January 18, 2024 / Simulab Corporation, a leader in...
LUND, SWEDEN / ACCESSWIRE / January 18, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today that the...